MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.060
-0.040 (-3.64%)
At close: Mar 28, 2025, 4:00 PM
1.100
+0.040 (3.77%)
After-hours: Mar 28, 2025, 6:35 PM EDT

MIRA Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
5.816.954.71.470.16
Research & Development
2.831.572.350.680.04
Operating Expenses
8.648.537.052.150.2
Operating Income
-8.64-8.53-7.05-2.15-0.2
Interest Expense
-2.73-3.46-0.01-0.02-0
Pretax Income
-11.24-11.98-7.06-2.18-0.2
Net Income
-11.24-11.98-7.06-2.18-0.2
Net Income to Common
-11.24-11.98-7.06-2.18-0.2
Shares Outstanding (Basic)
20191813-
Shares Outstanding (Diluted)
20191813-
Shares Change (YoY)
9.59%5.69%38.60%--
EPS (Basic)
-0.57-0.65-0.40-0.17-
EPS (Diluted)
-0.57-0.65-0.40-0.17-
EBIT
-8.64-8.53-7.05-2.15-0.2
Advertising Expenses
-0.1---
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q